Back

Prasugrel based de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trial

31 August 2020 (09:55 - 10:05)
Organised by:
Congress Presentation Part of: Latest Randomized Results on Antiplatelet Therapy Pharmacotherapy ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Hyo-Soo Kim

Seoul National University Hospital, Seoul (Korea (Republic of))

3 More presentations in this session

Presentation thumbnail
Online session - Latest Randomized Results on Antiplatelet Therapy - Host and Discussant
Professor M. Roffi (Geneva, CH)
Presentation thumbnail
The effect of one year postoperative ticagrelor in addition to aspirin on saphenous vein graft patency in patients undergoing CABG – a randomized, multi-center, double-blind, placebo-controlled trial.
Miss L. Willemsen (Nieuwegein, NL)
Slides Video
Presentation thumbnail
Downstream or upstream P2Y12 receptor blockers in NSTE-ACS
Associate Professor G. Tarantini (Padova, IT)
Slides Video

Access the full session

Session thumbnail
Latest Randomized Results on Antiplatelet Therapy

The Event

Event poster

ESC Congress 2020

31 August 2020 09:55 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources